Lek focused on continued development and progress through planned investments in employee education and training

18. 11. 2010

At this year’s 10th annual Education Management conference, held at Otočec by Planet GV and the SOFOS Education Management Institute, Lek, a Sandoz company, once again received a TOP 10 Education Management award. Awards were also presented to nine other companies and organizations which systematically invest in knowledge and provide for the education and training of their employees. The award was presented by the chairman of the commission Dr. Bogdan Lipičnik to Samo Roš, Executive Director of Human Resources and Member of the Lek Board of Management.

Winning a TOP 10 Education Management award in 2010 is a confirmation of Lek’s professionally planned work process and investments in the education and personal development of its associates. Lek management is aware that providing continuous education, training and advancement for its associates is crucially important for the company’s growth and development. Samo Roš, Executive Director of Human Resources and Member of the Lek Board of Management said upon receiving this year’s award: “As in every year to date, in 2009 Lek invested in development extensively and in a planned manner, and provided continuous education, training and advancement for its associates, which we are very proud of. In uncertain economic conditions, this kind of support is all the more important for the company’s continued development. Therefore this year’s award is particularly meaningful. It shows that we don’t neglect our work even in straitened economic circumstances and that we are oriented towards continued development and progress. Our associates are therefore deserving of special praise for their participation and for the organization and implementation of activities in the field of education and training.”

In 2009, Lek organized numerous internal and external courses on various topics, and as a part of a global company our associates also have the opportunity to attend courses abroad. Through participating in international projects, Lek associates have a unique opportunity to study with and learn from major foreign professionals.

The selection of the recipients of the awards for the top ten best practices among companies and organizations in Slovenia in the field of systematic investment in knowledge and stimulating the accelerated development of educational practices and the enhanced reputation of the field of education was performed by a three-member expert panel comprising Dr. Bogdan Lipičnik (Faculty of Economics, University of Ljubljana), Dr. Daniela Brečko (Planet GV) and Monika Zalokar (Planet GV). In addition to Lek, Top 10 Education Management 2010 awards were received by: GKN Driveline Slovenia, Helios, Krka, Revoz, Sava, the Šoštanj Thermoelectric Power Plant, Unicredit Bank Slovenia, the Triglav Insurance Company, and the Health Insurance Institute of Slovenia.

The participants at this year’s conference focused on methods and avenues for life-long learning of skills and the development of employees’ personal potentials. They discussed successful educational programs in organizations and companies and trends in the field of education management.

* * *

Lek, a Sandoz company, is one of the pillars of leading world generics company Sandoz. Its role within Sandoz is to act as: a global development center for products and technologies; a global manufacturing center for active pharmaceutical ingredients and medicines; a competence center for the development of vertically integrated products; a Sandoz competence center in the field of development and manufacturing of biosimilar products; and, a supply center for the markets of Central and Eastern Europe (CEE), South East Europe (SEE) and Commonwealth of Independent States (CIS), and it is responsible for sales on the Slovenian market. For further information please visit http://www.lek.si/eng/.

Sandoz, a Division of the Novartis group, is a global leader in the field of generic pharmaceuticals, offering a wide array of high-quality, affordable products that are no longer protected by patents. Sandoz has a portfolio of approximately 1000 compounds and sells its products in more than 130 countries. Key product groups include antibiotics, treatments for central nervous system disorders, gastrointestinal medicines, cardiovascular treatments and hormone therapies. Sandoz develops, produces and markets these medicines along with pharmaceutical and biotechnological active substances and anti-infectives. In addition to strong organic growth in recent years, Sandoz has made a series of acquisitions including Lek (Slovenia), Sabex (Canada), Hexal (Germany), Eon Labs (US), EBEWE Pharma (Austria) and Oriel Therapeutics (US). In 2009, Sandoz employed around 23,000 people worldwide and posted sales of USD 7.5 billion. For further information please visit www.sandoz.com.

Novartis provides healthcare solutions that address the evolving needs of patients and societies. Focused solely on healthcare, Novartis offers a diversified portfolio to best meet these needs: innovative medicines, cost-saving generic pharmaceuticals, preventive vaccines, diagnostic tools and consumer health products. Novartis is the only company with leading positions in these areas. In 2009, the Group’s continuing operations achieved net sales of USD 44.3 billion, while approximately USD 7.5 billion was invested in R&D activities throughout the Group. Headquartered in Basel, Switzerland, Novartis Group companies employ approximately 100,000 full-time-equivalent associates and operate in more than 140 countries around the world. For more information, please visit www.novartis.com.

* * *

This press release contains statements and conclusions based on projections of Lek’s future business operations. These estimates are derived from the best information currently available. In case these forecasts prove unreliable, the actual results could prove different from those projected.

- end -

For further information contact:
Katarina Klemenc Dinjaški
Corporate Communications
Lek Pharmaceuticals d.d.
Phone: + 386 1 580 22 43
Fax: + 386 1 580 24 32